Study Attempts to Create New Beta Cells
Procter & Gamble Pharmaceuticals is sponsoring a new study on the safety and efficacy of INGAP-peptide.
The phase 2 study is interventional, randomized, double blinded, and placebo controlled.
Requirements for type 2s who wish to participate are:
- You must be between 35 and 70 years old
- You must have an A1C between 6.5% and 10%
- You must have a fasting C-peptide of less than 0.3 ng/ml
Clinical Trials-National Institutes of Health, November 2003Click Here To View Or Post Comments